Newsflash: Lowering Lp(a) has zero effect on heart health outcomes.
The most straightforward explanation as to why lowering Lp(a) had zero effect on heart disease outcomes would seem to be because Lp(a) is not actually the cause of heart disease … it’s merely an associated symptom.
That Novartis has been pushing Lp(a) testing well before this distinction between cause and effect has been established would seem to be motivated by their expecting to have a “breakthrough” drug to market that lowers something they’ve helped raise anxiety about.
This is similar to so many erroneous beliefs that confuse cause and effect (viz. LDL?) 
